Download PDF
CC BY-NC-ND 4.0 · Asian J Neurosurg
DOI: 10.1055/s-0044-1795165
Original Article

Should Not Children with Ventriculoatrial Shunts Be Taking Aspirin? An Update: 0% Distal Malfunction

Suhas Udayakumaran
1   Division of Paediatric Neurosurgery, Department of Neurosurgery, Amrita Institute of Medical Sciences and Research Centre, Kochi, India
,
Shine Kumar
2   Department of Pediatric Cardiology, Amrita Institute of Medical Sciences and Research Centre, Kochi, India
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Background Ventriculoatrial (VA) shunts have the potential to preserve life in the event of failure of ventriculoperitoneal (VP) shunts. Contrary to VP shunts, they are susceptible to consequences, particularly cardiac problems. There are no established guidelines for screening patients following VA shunt placement regarding prevention, anticoagulant treatment, or risk factor screening.

Objective We aim to investigate aspirin's potential function and effectiveness in enhancing shunt survival and preventing secondary morbidity from distal thrombosis in children with VA shunts.

Materials and Methods The study's design is prospective and observational. It began in 2011 and is ongoing. Before inclusion in the study, we obtained clearance from the hospital ethics board and consent from the family. All patients with VA shunts were given a once-a-day antiplatelet dose of 5 mg/kg of aspirin from the first postoperative day. The study's primary end points include: (1) Major distal end malfunction documented on echocardiography or (2) any cardiac complications directly associated with the VA shunt.

Results Since March 2011, 13 patients have been followed up. So far, no cardiac complications have been ascribed to VA shunts in any of the patients. The current follow-up period is 28 to 170 months. Patient follow-up is continuing.

Conclusion Our observations regarding the efficacy and safety of aspirin in VA shunts are encouraging. However, sufficient time would be needed to establish its effectiveness in chronic sequelae such as pulmonary hypertension.

Keywords

silicone - complications - thromboprophylaxis

Note

This study was previously presented as a platform presentation at ISPN 2023, held at Vina de la Mer, Chile.


Authors' Contributions

S.U. contributed to the concept, study design, statistics, drafting, and final revision. S.K. contributed to the concept and final revision.


Ethical Approval

This study protocol was reviewed and approved by the Institutional Ethics Committee, AIMS, approval number IECAIMS 22200-2019.




Publication History

Article published online:
21 November 2024

© 2024. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Bonderman D, Jakowitsch J, Adlbrecht C. et al. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost 2005; 93 (03) 512-516
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Haasnoot K, van Vught AJ. Pulmonary hypertension complicating a ventriculo-atrial shunt. Eur J Pediatr 1992; 151 (10) 748-750
    CrossrefPubMedSearch in Google Scholar
  • 3 Kádár K, Hartyánszky I, Király L, Bendig L. Right heart thrombus in infants and children. Pediatr Cardiol 1991; 12 (01) 24-27
    CrossrefPubMedSearch in Google Scholar
  • 4 Milton CA, Sanders P, Steele PM. Late cardiopulmonary complication of ventriculo-atrial shunt. Lancet 2001; 358 (9293) 1608
    CrossrefPubMedSearch in Google Scholar
  • 5 Wells CA, Senior AJ. Coronary sinus thrombosis and myocardial infarction secondary to ventriculoatrial shunt insertion. J Pediatr Surg 1990; 25 (12) 1214-1215
    CrossrefPubMedSearch in Google Scholar
  • 6 Sleigh G, Dawson A, Penny WJ. Cor pulmonale as a complication of ventriculo-atrial shunts reviewed. Dev Med Child Neurol 1993; 35 (01) 74-78
    CrossrefPubMedSearch in Google Scholar
  • 7 Wilkinson N, Sood S, Ham SD, Gilmer-Hill H, Fleming P, Rajpurkar M. Thrombosis associated with ventriculoatrial shunts. J Neurosurg Pediatr 2008; 2 (04) 286-291
    CrossrefPubMedSearch in Google Scholar
  • 8 Wu D, Guan Z, Xiao L, Li D. Thrombosis associated with ventriculoatrial shunts. Neurosurg Rev 2022; 45 (02) 1111-1122
    CrossrefPubMedSearch in Google Scholar
  • 9 Yurtseven T, Erşahin Y, Kitiş O, Mutluer S. Thrombosis and thrombophilebitis of the internal jugular vein as a very rare complication of the ventriculoatrial shunt. Clin Neurol Neurosurg 2005; 107 (02) 144-146
    CrossrefPubMedSearch in Google Scholar
  • 10 Kluge S, Baumann HJ, Regelsberger J. et al. Development of pulmonary hypertension in adults after ventriculoatrial shunt implantation. Respiration 2009; 78 (01) 30-35
    CrossrefPubMedSearch in Google Scholar
  • 11 Kluge S, Baumann HJ, Regelsberger J. et al. Pulmonary hypertension after ventriculoatrial shunt implantation. J Neurosurg 2010; 113 (06) 1279-1283
    CrossrefPubMedSearch in Google Scholar
  • 12 Ignelzi RJ, Kirsch WM. Follow-up analysis of ventriculoperitoneal and ventriculoatrial shunts for hydrocephalus. J Neurosurg 1975; 42 (06) 679-682
    CrossrefPubMedSearch in Google Scholar
  • 13 Borgbjerg BM, Gjerris F, Albeck MJ, Hauerberg J, Børgesen SV. A comparison between ventriculo-peritoneal and ventriculo-atrial cerebrospinal fluid shunts in relation to rate of revision and durability. Acta Neurochir (Wien) 1998; 140 (05) 459-464 , discussion 465
    CrossrefPubMedSearch in Google Scholar
  • 14 Vernet O, Campiche R, de Tribolet N. Long-term results after ventriculoatrial shunting in children. Childs Nerv Syst 1993; 9 (05) 253-255
    CrossrefPubMedSearch in Google Scholar
  • 15 Keucher TR, Mealey Jr J. Long-term results after ventriculoatrial and ventriculoperitoneal shunting for infantile hydrocephalus. J Neurosurg 1979; 50 (02) 179-186
    CrossrefPubMedSearch in Google Scholar
  • 16 Crome L, Erdohazi M. Main pathological findings in hydrocephalic children treated by ventriculo-atrial shunt. Arch Dis Child 1966; 41 (216) 179-182
    CrossrefPubMedSearch in Google Scholar
  • 17 Lundar T, Langmoen IA, Hovind KH. Fatal cardiopulmonary complications in children treated with ventriculoatrial shunts. Childs Nerv Syst 1991; 7 (04) 215-217
    CrossrefPubMedSearch in Google Scholar
  • 18 Hanak BW, Bonow RH, Harris CA, Browd SR. Cerebrospinal fluid shunting complications in children. Pediatr Neurosurg 2017; 52 (06) 381-400
    CrossrefPubMedSearch in Google Scholar
  • 19 Emery JL, Hilton HB. Lung and heart complications of the treatment of hydrocephalus by ventriculoauriculostomy. Surgery 1961; 50: 309-314
    PubMedSearch in Google Scholar
  • 20 Piatt Jr JH, Hoffman HJ. Cor pulmonale: a lethal complication of ventriculoatrial CSF diversion. Childs Nerv Syst 1989; 5 (01) 29-31
    CrossrefPubMedSearch in Google Scholar
  • 21 Udayakumaran S, Kumar S. Should not we be using aspirin in patients with a ventriculoatrial shunt? Borrowing a leaf from other specialities: a case for surrogate evidence. Childs Nerv Syst 2021; 37 (04) 1137-1142
    CrossrefPubMedSearch in Google Scholar
  • 22 Matharu GS, Kunutsor SK, Judge A, Blom AW, Whitehouse MR. Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med 2020; 180 (03) 376-384
    CrossrefPubMedSearch in Google Scholar
  • 23 Suzuki T, Michihata N, Hashimoto Y. et al. Association between aspirin dose and outcomes in patients with acute Kawasaki disease: a nationwide retrospective cohort study in Japan. Eur J Pediatr 2024; 183 (01) 415-424
    CrossrefPubMedSearch in Google Scholar
  • 24 Chiang MH, Liu HE, Wang JL. Low-dose or no aspirin administration in acute-phase Kawasaki disease: a meta-analysis and systematic review. Arch Dis Child 2021; 106 (07) 662-668
    CrossrefPubMedSearch in Google Scholar
  • 25 Shafiei SH, Rastegar M, Mirghaderi P, Siavashi B, Mortazavi SMJ. Comparison of low-dose (162 mg) and high-dose (650 mg) aspirin prophylaxis following total joint arthroplasty: a prospective cohort study. Ann Med Surg (Lond) 2023; 85 (05) 1461-1467
    CrossrefPubMedSearch in Google Scholar
  • 26 Chen Y, Chen F, Liao J, Han H, Li G, Zhou L. Low- or high-dose preventive aspirin use and risk of death from all-cause, cardiovascular disease, and cancer: a nationally representative cohort study. Front Pharmacol 2023; 14: 1099810
    CrossrefPubMedSearch in Google Scholar
  • 27 Monagle P, Chan AKC, Goldenberg NA. et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (02) e737S-e801S
    CrossrefPubMedSearch in Google Scholar
  • 28 Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited. Pediatrics 2004; 114 (06) e689-e693
    CrossrefPubMedSearch in Google Scholar
  • 29 Symss NP, Oi S. Is there an ideal shunt? A panoramic view of 110 years in CSF diversions and shunt systems used for the treatment of hydrocephalus: from historical events to current trends. Childs Nerv Syst 2015; 31 (02) 191-202
    CrossrefPubMedSearch in Google Scholar
  • 30 Entezami P, Devejian NS, Rubino S. et al. Vegetation of ventriculoatrial shunt managed via multidisciplinary surgical approach. World Neurosurg 2020; 144: 15-18
    CrossrefPubMedSearch in Google Scholar
  • 31 Gmeiner M, Wagner H, van Ouwerkerk WJR. et al. Long-term outcomes in ventriculoatrial shunt surgery in patients with pediatric hydrocephalus: retrospective single-center study. World Neurosurg 2020; 138: e112-e118
    CrossrefPubMedSearch in Google Scholar
  • 32 Rymarczuk GN, Keating RF, Coughlin DJ. et al. A comparison of ventriculoperitoneal and ventriculoatrial shunts in a population of 544 consecutive pediatric patients. Neurosurgery 2020; 87 (01) 80-85
    CrossrefPubMedSearch in Google Scholar
  • 33 Al-Schameri AR, Hamed J, Baltsavias G. et al. Ventriculoatrial shunts in adults, incidence of infection, and significant risk factors: a single-center experience. World Neurosurg 2016; 94: 345-351
    CrossrefPubMedSearch in Google Scholar
  • 34 Burström G, Andresen M, Bartek Jr J, Fytagoridis A. Subacute bacterial endocarditis and subsequent shunt nephritis from ventriculoatrial shunting 14 years after shunt implantation. BMJ Case Rep 2014; 2014: bcr2014204655
    CrossrefPubMedSearch in Google Scholar
  • 35 Babigumira M, Huang B, Werner S, Qunibi W. Delayed manifestation of shunt nephritis: a case report and review of the literature. Case Rep Nephrol 2017; 2017: 1867349
    PubMedSearch in Google Scholar
  • 36 Noe HN, Roy III S. Shunt nephritis. J Urol 1981; 125 (05) 731-733
    CrossrefPubMedSearch in Google Scholar
  • 37 Pradini-Santos L, Craven CL, Watkins LD, Toma AK. Ventriculoatrial shunt catheter tip migration causing tricuspid regurgitation: case report and review of the literature. World Neurosurg 2020; 136: 83-89
    CrossrefPubMedSearch in Google Scholar
  • 38 Matsubara N, Miyachi S, Tsukamoto N. [Intracardiac migration of a ventriculoatrial shunt catheter treated by endovascular transvenous retrieval]. No Shinkei Geka 2012; 40 (06) 539-545
    PubMedSearch in Google Scholar
  • 39 Hung CC, Chuang HY, Lin HL, Chu YT, Cheng CH. Intramuscular migration of venous catheter as a rare complication of ventriculoatrial shunt: case report and literature review. J Neurol Surg A Cent Eur Neurosurg 2017; 78 (04) 412-416
    Thieme ConnectPubMedSearch in Google Scholar
  • 40 Vargas-Barron J, Buenfil-Medina C, Sanchez-Ugarte T. et al. Ventriculoatrial shunts for hydrocephalus and cardiac valvulopathy: an echocardiographic evaluation. Am Heart J 1991; 121 (05) 1498-1501
    CrossrefPubMedSearch in Google Scholar
  • 41 Akram Q, Saravanan D, Levy R. Valvuloplasty for tricuspid stenosis caused by a ventriculoatrial shunt. Catheter Cardiovasc Interv 2011; 77 (05) 722-725
    CrossrefPubMedSearch in Google Scholar
  • 42 Natarajan A, Mazhar S. Right heart complications of ventriculoatrial shunt. Eur Heart J 2011; 32 (17) 2134
    CrossrefPubMedSearch in Google Scholar
  • 43 Pascual JM, Prakash UB. Development of pulmonary hypertension after placement of a ventriculoatrial shunt. Mayo Clin Proc 1993; 68 (12) 1177-1182
    CrossrefPubMedSearch in Google Scholar
  • 44 Sperling DR, Patrick JR, Anderson FM, Fyler DC. Cor pulmonale secondary to ventriculoauriculostomy. Am J Dis Child 1964; 107: 308-315
    PubMedSearch in Google Scholar
  • 45 Nugent GR, Lucas R, Judy M, Bloor BM, Warden H. Thrombo-embolic complications of ventriculo-atrial shunts. Angiocardiographic and pathologic correlations. J Neurosurg 1966; 24 (01) 34-42
    CrossrefPubMedSearch in Google Scholar
  • 46 Sharma R, Mcleod AA. Pulmonary hypertension: a rare but serious complication of ventriculoatrial shunts. Hosp Med 2004; 65 (04) 242-243
    CrossrefPubMedSearch in Google Scholar
  • 47 Ladouceur D, Giroux M. Echocardiographic detection of intracardiac thrombi complicating ventriculo-atrial shunt. Report of two cases. Pediatr Neurosurg 1994; 20 (01) 68-72
    CrossrefPubMedSearch in Google Scholar
  • 48 Drucker MH, Vanek VW, Franco AA, Hanson M, Woods L. Thromboembolic complications of ventriculoatrial shunts. Surg Neurol 1984; 22 (05) 444-448
    CrossrefPubMedSearch in Google Scholar
  • 49 Lam CH, Villemure JG. Comparison between ventriculoatrial and ventriculoperitoneal shunting in the adult population. Br J Neurosurg 1997; 11 (01) 43-48
    CrossrefPubMedSearch in Google Scholar
  • 50 Al-Natour MS, Entezami P, Nazzal MM. et al. Superior vena cava syndrome with retropharyngeal edema as a complication of ventriculoatrial shunt. Clin Case Rep 2015; 3 (10) 777-780
    CrossrefPubMedSearch in Google Scholar
  • 51 Kuriakose P, Colon-Otero G, Paz-Fumagalli R. Risk of deep venous thrombosis associated with chest versus arm central venous subcutaneous port catheters: a 5-year single-institution retrospective study. J Vasc Interv Radiol 2002; 13 (2 Pt 1): 179-184
    CrossrefPubMedSearch in Google Scholar
  • 52 D'Alonzo GE, Barst RJ, Ayres SM. et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115 (05) 343-349
    CrossrefPubMedSearch in Google Scholar
  • 53 Delavari N, Mureb MC, Yaun A, Wisoff JH, Harter DH, Hidalgo ET. Intrareservoir administration of alteplase to treat a distal ventriculoatrial shunt obstruction. World Neurosurg 2020; 135: 259-261
    CrossrefPubMedSearch in Google Scholar
  • 54 Hudgins RJ, Boydston WR, Gilreath CL. Urokinase in the treatment of shunt malfunctions caused by thrombus. Pediatr Neurosurg 1996; 25 (06) 315-320
    CrossrefPubMedSearch in Google Scholar
  • 55 Talner NS, Liu HY, Oberman HA, Schmidt RW. Thromboembolism complicating Holter valve shunt. A clinicopathologic study of four patients treated with this procedure for hydrocephalus. Am J Dis Child 1961; 101: 602-609
    CrossrefPubMedSearch in Google Scholar
  • 56 Vandersteene J, Baert E, Planckaert GMJ. et al. The influence of cerebrospinal fluid on blood coagulation and the implications for ventriculovenous shunting. J Neurosurg 2018; 130 (04) 1244-1251
    CrossrefPubMedSearch in Google Scholar
  • 57 Patrono C, Morais J, Baigent C. et al. Antiplatelet agents for the treatment and prevention of coronary atherothrombosis. J Am Coll Cardiol 2017; 70 (14) 1760-1776
    CrossrefPubMedSearch in Google Scholar
  • 58 Mahnke CB, Boyle GJ, Janosky JE, Siewers RD, Pigula FA. Anticoagulation and incidence of late cerebrovascular accidents following the Fontan procedure. Pediatr Cardiol 2005; 26 (01) 56-61
    CrossrefPubMedSearch in Google Scholar
  • 59 Lupinetti FM, Duncan BW, Scifres AM. et al. Intermediate-term results in pediatric aortic valve replacement. Ann Thorac Surg 1999; 68 (02) 521-525 , discussion 525–526
    CrossrefPubMedSearch in Google Scholar
  • 60 Sinclair AJ, Fox CK, Ichord RN. et al. Stroke in children with cardiac disease: report from the International Pediatric Stroke Study Group Symposium. Pediatr Neurol 2015; 52 (01) 5-15
    CrossrefPubMedSearch in Google Scholar
  • 61 Boucher AA, Heneghan JA, Jang S. et al. A narrative review of postoperative anticoagulation therapy for congenital cardiac disease. Front Surg 2022; 9: 907782
    CrossrefPubMedSearch in Google Scholar
  • 62 Mohanty S, Vaidyanathan B. Anti-platelet agents in pediatric cardiac practice. Ann Pediatr Cardiol 2013; 6 (01) 59-64
    CrossrefPubMedSearch in Google Scholar
  • 63 Kuffer F. Prophylactic long-term anticoagulant treatment of hydrocephalic patients with ventriculo-atrial shunts. Dev Med Child Neurol Suppl 1976; (37) 74-77
    CrossrefPubMedSearch in Google Scholar
  • 64 Fu SH, Wang CY. Is it time to comprehensively utilize low-dose aspirin for preventing venous thromboembolism after total knee arthroplasty?: Commentary on an article by Monish S. Lavu, MHM, et al.: “Low-dose aspirin is the safest prophylaxis for prevention of venous thromboembolism after total knee arthroplasty across all patient risk profiles”. J Bone Joint Surg Am 2024; 106 (14) e29
    CrossrefPubMedSearch in Google Scholar
  • 65 Lavu MS, Porto JR, Hecht II CJ. et al. Low-dose aspirin is the safest prophylaxis for prevention of venous thromboembolism after total knee arthroplasty across all patient risk profiles. J Bone Joint Surg Am 2024; 106 (14) 1256-1267
    CrossrefPubMedSearch in Google Scholar
  • 66 Mills JA. Aspirin, the ageless remedy?. N Engl J Med 1991; 325 (18) 1303-1304
    CrossrefPubMedSearch in Google Scholar
  • 67 Za P, Papalia GF, Franceschetti E, Rizzello G, Adravanti P, Papalia R. Aspirin is a safe and effective thromboembolic prophylaxis after total knee arthroplasty: a systematic review and meta-analysis. Knee Surg Sports Traumatol Arthrosc 2023; 31 (10) 4407-4421
    CrossrefPubMedSearch in Google Scholar